Sales and Marketing

Showing 15 posts of 11527 posts found.

Mounting US pricing pressures cutting into quarterly sales, Novartis admits

May 31, 2017 Research and Development, Sales and Marketing Novartis, Sandoz

Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …

BMS and Array BioPharma partner up to tackle colorectal cancer

May 30, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb

Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …

Glenmark greenlighted to market hypertension generic in US

May 30, 2017 Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension

Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …

FDA approves Novartis’ Zykadia as first-line lung cancer treatment

May 30, 2017 Manufacturing and Production, Sales and Marketing FDA, NSCLC, Novartis

The FDA has announced it has approved Novartis’ Zykadia (ceritinib) as a first line treatment in the expanded indication of …

Global Pricing Innovations and Pricing360 announce new strategic partnership

May 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …

WHO elects first African Director General

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …

New FDA Commissioner reveals strategy to drive down drug prices

May 26, 2017 Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, Trump, pricing

Deregulation, faster access and cheaper drug prices very quickly became the rallying cry for the Trump administration in the life …

Top Ten most popular articles on Pharmafile.com this week

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …

Puma Biotech’s breast cancer drug gets FDA committee nod

May 25, 2017 Medical Communications, Sales and Marketing Puma Biotech, breast cancer, neratinib

Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …

Neurocrine’s Ingrezza flops in Tourette’s for second time

May 25, 2017 Research and Development, Sales and Marketing Neurocrine Biosciences, tourette's

Neurocrine’s Tourette’s therapy Ingrezza (valbenazine) has been hit with yet another setback, flopping in a Phase 2 trial of paediatric …

26 die after attempting to replace Abbott’s blood pump controller themselves

May 24, 2017 Medical Communications, Sales and Marketing Abbott, FDA, Medical device, deaths

At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller …

MSD receives first FDA approval based on specific genetic feature

May 24, 2017 Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda

In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017 Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
The Gateway to Local Adoption Series

Latest content